Oceanside, California USA, Oct 6 – AOTI Inc. announced today that it is excited to again showcase its revolutionary Topical Wound Oxygen products at the upcoming Medica Expo in Dusseldorf, Germany from November 16-19.
“Medica is one of the pre-eminent medical product expos in the world” stated Dr. Mike Griffiths, CEO and President of AOTI. “providing AOTI an ideal venue to demonstrate the true value of its revolutionary wound care products to key medical sales and marketing professionals throughout Europe, the Middle-East, and Southeast Asia.
“We are pleased that healthcare professionals now recognize the real costs associated with the management of diabetic, venous, arterial and pressure ulcers and that adding Topical Wound Oxygen (TWO2) therapy to existing wound care best practices will not only reduce the total cost of care, but more importantly improve the patients quality of life”, added Griffiths.
About AOTI
AOTI is founded on a decade of experience in providing innovative solutions to resolve severe and chronic wounds worldwide. Our products reduce healthcare costs and improve the quality of life for patients with these debilitating illnesses. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is unsurpassed in fully closings Diabetic, Venous and Pressure ulcers alike. AOTI is a private company based in Oceanside, California USA and Galway, Ireland with offices throughout the globe. For more information, see www.dev.aotinc.net.
